Reply to Scheper and de Boer's comment on “Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococ...

by A. Becker, A. Becker, L. Kreitmann, L. Kreitmann, T. Ferry, T. Ferry, T. Ferry, T. Ferry
Published 2020-07-01

Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to <em>Staphylococcus</em> treated with a debridement, an...

by A. Becker, A. Becker, L. Kreitmann, L. Kreitmann, C. Triffaut-Fillit, C. Triffaut-Fillit, F. Valour, F. Valour, F. Valour, F. Valour, E. Mabrut, E. Forestier, O. Lesens, C. Cazorla, S. Descamps, B. Boyer, C. Chidiac, C. Chidiac, C. Chidiac, S. Lustig, S. Lustig, S. Lustig, E. Montbarbon, C. Batailler, C. Batailler, C. Batailler, T. Ferry, T. Ferry, T. Ferry, T. Ferry
Published 2020-02-01